249 related articles for article (PubMed ID: 32169731)
1. Efficacy and safety of duloxetine in osteoarthritis or chronic low back pain: a Systematic review and meta-analysis.
Weng C; Xu J; Wang Q; Lu W; Liu Z
Osteoarthritis Cartilage; 2020 Jun; 28(6):721-734. PubMed ID: 32169731
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Duloxetine on Osteoarthritis Knee Pain: A Meta-Analysis of Randomized Controlled Trials.
Wang ZY; Shi SY; Li SJ; Chen F; Chen H; Lin HZ; Lin JM
Pain Med; 2015 Jul; 16(7):1373-85. PubMed ID: 26176791
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of duloxetine in patients with knee osteoarthritis: a meta-analysis of randomised controlled trials.
Chen L; Gong M; Liu G; Xing F; Liu J; Xiang Z
Intern Med J; 2019 Dec; 49(12):1514-1523. PubMed ID: 30993832
[TBL] [Abstract][Full Text] [Related]
4. The short-term effect and safety of duloxetine in osteoarthritis: A systematic review and meta-analysis.
Gao SH; Huo JB; Pan QM; Li XW; Chen HY; Huang JH
Medicine (Baltimore); 2019 Nov; 98(44):e17541. PubMed ID: 31689755
[TBL] [Abstract][Full Text] [Related]
5. Onset of response with duloxetine treatment in patients with osteoarthritis knee pain and chronic low back pain: a post hoc analysis of placebo-controlled trials.
Williamson OD; Schroer M; Ruff DD; Ahl J; Margherita A; Sagman D; Wohlreich MM
Clin Ther; 2014 Apr; 36(4):544-51. PubMed ID: 24650448
[TBL] [Abstract][Full Text] [Related]
6. An Open-Label, 52-Week, Phase III Trial of Duloxetine in Japanese Patients with Chronic Low Back Pain.
Konno SI; Alev L; Oda N; Ochiai T; Enomoto H
Pain Med; 2019 Aug; 20(8):1479-1488. PubMed ID: 30856270
[TBL] [Abstract][Full Text] [Related]
7. Randomized, Double-blind, Placebo-controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients With Chronic Low Back Pain.
Konno S; Oda N; Ochiai T; Alev L
Spine (Phila Pa 1976); 2016 Nov; 41(22):1709-1717. PubMed ID: 27831985
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of duloxetine in Chinese patients with chronic pain due to osteoarthritis: a randomized, double-blind, placebo-controlled study.
Wang G; Bi L; Li X; Li Z; Zhao D; Chen J; He D; Wang CN; Dueñas H; Skljarevski V; Yue L
Osteoarthritis Cartilage; 2017 Jun; 25(6):832-838. PubMed ID: 28043937
[TBL] [Abstract][Full Text] [Related]
9. An Updated Systematic Review and Meta-analysis of Duloxetine for Knee Osteoarthritis Pain.
Chen B; Duan J; Wen S; Pang J; Zhang M; Zhan H; Zheng Y
Clin J Pain; 2021 Nov; 37(11):852-862. PubMed ID: 34483232
[TBL] [Abstract][Full Text] [Related]
10. Maintenance of effect of duloxetine in Chinese patients with pain due to osteoarthritis: 13-week open-label extension data.
Wang G; Bi L; Li X; Li Z; Zhao D; Chen J; He D; Wang CN; Wu T; Dueñas H; Skljarevski V; Yue L
BMC Musculoskelet Disord; 2019 Apr; 20(1):174. PubMed ID: 31010413
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of duloxetine in patients with knee osteoarthritis or chronic low back pain with early pain reduction: An exploratory post-hoc analysis of Japanese phase 3, 1-year extension studies.
Itoh N; Uchio Y; Tsuji T; Ishida M; Ochiai T; Konno S
J Orthop Sci; 2022 May; 27(3):717-724. PubMed ID: 33958268
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of duloxetine in chronic musculoskeletal pain: a systematic review and meta-analysis.
Ma X; Zhou S; Sun W; Sun J; Li G; Wang L; Guo Y
BMC Musculoskelet Disord; 2023 May; 24(1):394. PubMed ID: 37198620
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of duloxetine in patients with chronic low back pain.
Skljarevski V; Desaiah D; Liu-Seifert H; Zhang Q; Chappell AS; Detke MJ; Iyengar S; Atkinson JH; Backonja M
Spine (Phila Pa 1976); 2010 Jun; 35(13):E578-85. PubMed ID: 20461028
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysis.
Osani MC; Bannuru RR
Korean J Intern Med; 2019 Sep; 34(5):966-973. PubMed ID: 30871298
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial.
Upadhyaya HP; Arnold LM; Alaka K; Qiao M; Williams D; Mehta R
Pediatr Rheumatol Online J; 2019 May; 17(1):27. PubMed ID: 31138224
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of short-term duloxetine treatment in adults with generalized anxiety disorder: A meta-analysis.
Li X; Zhu L; Zhou C; Liu J; Du H; Wang C; Fang S
PLoS One; 2018; 13(3):e0194501. PubMed ID: 29558528
[TBL] [Abstract][Full Text] [Related]
17. Antidepressants in the treatment for chronic low back pain: questioning the validity of meta-analyses.
Williamson OD; Sagman D; Bruins RH; Boulay LJ; Schacht A
Pain Pract; 2014 Feb; 14(2):E33-41. PubMed ID: 24460577
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of duloxetine for the treatment of patients after TKA or THA: A systematic review and meta-analysis.
Zhou Y; Chen X; Chen C; Cao Y
Medicine (Baltimore); 2023 Aug; 102(34):e34895. PubMed ID: 37653762
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of duloxetine by prior NSAID use in the treatment of chronic osteoarthritis knee pain: A post hoc subgroup analysis of a randomized, placebo-controlled, phase 3 study in Japan.
Enomoto H; Fujikoshi S; Tsuji T; Sasaki N; Tokuoka H; Uchio Y
J Orthop Sci; 2018 Nov; 23(6):1019-1026. PubMed ID: 30126675
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of Biphasic-Release Hydrocodone Bitartrate/Acetaminophen Tablets (MNK-155): A Phase III, Multicenter, Open-Label Study in Patients With Osteoarthritis or Chronic Low Back Pain.
Zheng Y; Kostenbader K; Barrett T; Hisaw E; Giuliani MJ; Chen Y; Young JL
Clin Ther; 2015 Jun; 37(6):1235-47. PubMed ID: 25913923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
